Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NICHD

METHOD FOR MEASURING THE MECHANICAL PROPERTIES OF THE COLLAGEN NETWORK IN CARTILAGE

  • Read more about METHOD FOR MEASURING THE MECHANICAL PROPERTIES OF THE COLLAGEN NETWORK IN CARTILAGE
Patent Cooperation Treaty
PCT/US1998/002727
Filed on 1998-02-13

VACCINE AGAINST ESCHERICHIA COLI 0157 INFECTION, COMPOSED OF DETOXIFIED LPS CONJUGATED TO PROTEINS

  • Read more about VACCINE AGAINST ESCHERICHIA COLI 0157 INFECTION, COMPOSED OF DETOXIFIED LPS CONJUGATED TO PROTEINS
Patent Cooperation Treaty
PCT/US1998/014976
Filed on 1998-07-20

METHODS OF INHIBITING CANCER CELLS WITH ADNF III ANTISENSE OLIGONUCLEOTIDES

  • Read more about METHODS OF INHIBITING CANCER CELLS WITH ADNF III ANTISENSE OLIGONUCLEOTIDES
Patent Cooperation Treaty
PCT/US2000/020742
Filed on 2000-07-28

METHODS AND COMPOSITIONS FOR p300/CBP ASSOCIATED TRANSCRIPTIONAL CO-FACTOR P/CAF

  • Read more about METHODS AND COMPOSITIONS FOR p300/CBP ASSOCIATED TRANSCRIPTIONAL CO-FACTOR P/CAF
Patent Cooperation Treaty
PCT/US1997/012877
Filed on 1997-07-23

USE OF RECOMBINANT HUMAN UTEROGLOBIN IN TREATMENT OF INFLAMMATORY AND FIBROTIC CONDITIONS

  • Read more about USE OF RECOMBINANT HUMAN UTEROGLOBIN IN TREATMENT OF INFLAMMATORY AND FIBROTIC CONDITIONS
US Patent 6,255,281
Filed on 1997-05-28

PURIFICATION OF HUMAN CHORIONIC GONADOTROPIN BETA-CORE MOLECULE AND PREPARATION OF ANTIBODIES WITH SPECIFICITY...

  • Read more about PURIFICATION OF HUMAN CHORIONIC GONADOTROPIN BETA-CORE MOLECULE AND PREPARATION OF ANTIBODIES WITH SPECIFICITY...
US Application 08/888,001
Filed on 1997-07-03

21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS

  • Read more about 21-SUBSTITUTED PROGESTERONE DERIVATIVES AS NEW ANTIPROGESTATIONAL AGENTS
Patent Cooperation Treaty
PCT/US1997/007373
Filed on 1997-04-30

METHOD AND SYSTEM FOR MEASURING THE DIFFUSION TENSOR AND FOR DIFFUSION TENSOR IMAGING

  • Read more about METHOD AND SYSTEM FOR MEASURING THE DIFFUSION TENSOR AND FOR DIFFUSION TENSOR IMAGING
US Patent 5,539,310
Filed on 1995-08-07

NATURAL HUMAN CHORIONIC GONADOTROPIN B-CORE MOLECULE

  • Read more about NATURAL HUMAN CHORIONIC GONADOTROPIN B-CORE MOLECULE
US Patent 5,674,983
Filed on 1995-05-23

GOSSYPOL FOR THE TREATMENT OF CANCER

  • Read more about GOSSYPOL FOR THE TREATMENT OF CANCER
US Patent 6,114,397
Filed on 1995-01-27

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 138
  • Page 139
  • Page 140
  • Page 141
  • Page 142
  • Page 143
  • Page 144
  • Page 145
  • Page 146
  • …
  • Next page ››
  • Last page Last »
Subscribe to NICHD
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health